A phase II single arm study of pazopanib and paclitaxel as first line treatment for patients with advanced melanoma

  • Fruehauf, J. P.
  • Alger, B.
  • Hsiang, D.
  • Pham, H. T.
  • Sender, L. S.
  • Bettis, C.
  • Casey, C.
  • Jakowatz, J. G.

  • 1UCI Comprehensive Cancer Center, Orange, CA; 2University of California, Irvine, Orange, CA; 3University of California, Irvine Medical Center, Orange, CA; 4UC Irvine Medical Center, Orange, CA; 5UC Irvine Chao Family Comprehensive Cancer Center, Orange, CA

Pigment Cell & Melanoma Research 28(5):p 618, September 2015.
Copyright © 2015 John Wiley & Sons, Ltd